GSK2118436 (dabrafenib)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for GSK2118436 (dabrafenib), covering 2017-11-13 to 2017-11-14. Get the full timeline:
Most recent: Clinical Trial Update: An Open Label Study to Examine the Effects of a High-Fat Meal and Particle Size on the Pharmacokinetics of Orally Administered GSK2118436 in Subjects With BRAF Mutation Positive Tumor [Phase 1]